CN102549142B - 在连续细胞培养中产生所关心多肽或病毒的方法 - Google Patents

在连续细胞培养中产生所关心多肽或病毒的方法 Download PDF

Info

Publication number
CN102549142B
CN102549142B CN201080036754.2A CN201080036754A CN102549142B CN 102549142 B CN102549142 B CN 102549142B CN 201080036754 A CN201080036754 A CN 201080036754A CN 102549142 B CN102549142 B CN 102549142B
Authority
CN
China
Prior art keywords
cell
less
cells
culture
culture system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201080036754.2A
Other languages
English (en)
Chinese (zh)
Other versions
CN102549142A (zh
Inventor
L·格里尔伯格
M·赖特尔
D·弗莱施汉德尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Baxter Healthcare SA
Baxter International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Healthcare SA, Baxter International Inc filed Critical Baxter Healthcare SA
Publication of CN102549142A publication Critical patent/CN102549142A/zh
Application granted granted Critical
Publication of CN102549142B publication Critical patent/CN102549142B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M3/00Tissue, human, animal or plant cell, or virus culture apparatus
    • C12M3/006Cell injection or fusion devices
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • C12N5/0056Xeno-free medium
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489Metalloendopeptidases (3.4.24)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/98Xeno-free medium and culture conditions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/00051Methods of production or purification of viral material
    • C12N2710/00052Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24Metalloendopeptidases (3.4.24)
    • C12Y304/24087ADAMTS13 endopeptidase (3.4.24.87)
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/52Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Sustainable Development (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
CN201080036754.2A 2009-07-31 2010-08-02 在连续细胞培养中产生所关心多肽或病毒的方法 Active CN102549142B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23031309P 2009-07-31 2009-07-31
US61/230,313 2009-07-31
PCT/EP2010/061191 WO2011012725A1 (en) 2009-07-31 2010-08-02 Method of producing a polypeptide or virus of interest in a continuous cell culture

Publications (2)

Publication Number Publication Date
CN102549142A CN102549142A (zh) 2012-07-04
CN102549142B true CN102549142B (zh) 2014-07-16

Family

ID=42668436

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201080036754.2A Active CN102549142B (zh) 2009-07-31 2010-08-02 在连续细胞培养中产生所关心多肽或病毒的方法

Country Status (22)

Country Link
US (4) US8580554B2 (cg-RX-API-DMAC7.html)
EP (2) EP2459697B1 (cg-RX-API-DMAC7.html)
JP (2) JP5808742B2 (cg-RX-API-DMAC7.html)
KR (2) KR101752789B1 (cg-RX-API-DMAC7.html)
CN (1) CN102549142B (cg-RX-API-DMAC7.html)
AU (1) AU2010277490B2 (cg-RX-API-DMAC7.html)
BR (1) BR112012002137B8 (cg-RX-API-DMAC7.html)
CA (1) CA2769354A1 (cg-RX-API-DMAC7.html)
CO (1) CO6491119A2 (cg-RX-API-DMAC7.html)
DK (1) DK2459697T3 (cg-RX-API-DMAC7.html)
EA (1) EA022219B1 (cg-RX-API-DMAC7.html)
ES (1) ES2705206T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20182165T1 (cg-RX-API-DMAC7.html)
IN (1) IN2012DN00899A (cg-RX-API-DMAC7.html)
MX (2) MX2012001274A (cg-RX-API-DMAC7.html)
NZ (1) NZ597742A (cg-RX-API-DMAC7.html)
PL (1) PL2459697T3 (cg-RX-API-DMAC7.html)
PT (1) PT2459697T (cg-RX-API-DMAC7.html)
SG (1) SG178176A1 (cg-RX-API-DMAC7.html)
SI (1) SI2459697T1 (cg-RX-API-DMAC7.html)
TR (1) TR201900213T4 (cg-RX-API-DMAC7.html)
WO (1) WO2011012725A1 (cg-RX-API-DMAC7.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201809632XA (en) 2010-07-08 2018-12-28 Baxalta Inc METHOD OF PRODUCING RECOMBINANT HIGH MOLECULAR WEIGHT vWF IN CELL CULTURE
SI2665806T1 (sl) * 2011-01-17 2021-11-30 F. Hoffmann-La Roche Ag Aparat za separacijo
DK3626737T3 (da) 2011-05-13 2024-02-05 Octapharma Ag Fremgangsmåde til at forøge produktiviteten af eukaryote celler i produktionen af rekombinant fviii
LT2837680T (lt) 2011-07-01 2020-07-10 Amgen Inc. Žinduolių ląstelių kultūra
CN203129697U (zh) 2013-02-05 2013-08-14 客贝利(厦门)休闲用品有限公司 一种帐篷架杆
CA2856455C (en) 2011-11-24 2022-08-23 Genethon Scalable lentiviral vector production system compatible with industrial pharmaceutical applications
US9574167B2 (en) 2013-02-15 2017-02-21 Pharyx, Inc. Methods and apparatus for independent control of product and reactant concentrations
EP2964663A2 (en) 2013-03-08 2016-01-13 Genzyme Corporation Continuous purification of therapeutic proteins
US9217168B2 (en) 2013-03-14 2015-12-22 Momenta Pharmaceuticals, Inc. Methods of cell culture
DK2976418T3 (da) 2013-03-19 2021-01-11 Cmc Biologics As Fremgangsmåde til fremstilling af et produkt (f.eks. polypeptid) i en kontinuerlig cellekulturfermenteringsproces
CN105473712B (zh) * 2013-08-30 2022-05-27 葛兰素史密丝克莱恩生物有限公司 在细胞培养物中大规模生产病毒
US11390663B2 (en) 2013-10-11 2022-07-19 Regeneron Pharmaceuticals, Inc. Metabolically optimized cell culture
TWI709569B (zh) 2014-01-17 2020-11-11 美商健臻公司 無菌層析樹脂及其用於製造方法的用途
TWI709570B (zh) 2014-01-17 2020-11-11 美商健臻公司 無菌層析法及製法
AU2015240354A1 (en) 2014-04-01 2016-11-17 Advantech Bioscience Farmaceutica Ltda. Stabilization of Factor VIII without calcium as an excipient
CN106413741A (zh) 2014-04-01 2017-02-15 爱德技术生物科学有限公司 含低糖‑甘氨酸的稳定因子viii制剂
EP3158055B1 (en) * 2014-06-13 2019-09-11 CSL Limited Improved production of recombinant von willebrand factor in a bioreactor
KR102739324B1 (ko) * 2016-01-26 2024-12-09 베링거 인겔하임 인터내셔날 게엠베하 연결된 관류 대 연속-유동식 교반-탱크 반응기 세포 배양 시스템
KR102414290B1 (ko) 2016-04-15 2022-06-29 베링거 인겔하임 인터내셔날 게엠베하 세포 보유 장치 및 방법
CN110023482B (zh) * 2016-12-21 2023-05-02 豪夫迈·罗氏有限公司 真核细胞的生长控制
IL321253A (en) 2018-05-01 2025-08-01 Amgen Inc Antibodies with a modulated glycan profile
WO2019239780A1 (ja) * 2018-06-15 2019-12-19 富士フイルム株式会社 細胞培養方法、細胞培養装置、及び生産物の製造方法
BR112021003420A2 (pt) 2018-08-31 2021-05-18 Genzyme Corporation resina cromatográfica estéril e uso da mesma em processos de manufatura
CN113355297A (zh) * 2021-06-23 2021-09-07 吉林冠界生物技术有限公司 一种灌流式培养全悬浮mdck细胞生产重组禽流感病毒的方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1596302A (zh) * 2001-11-28 2005-03-16 桑多斯有限公司 细胞培养方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5019512A (en) 1989-03-17 1991-05-28 Baxter International Inc. Spin filter for removing substantially cell-free culture medium from suspension cell culture system
US5626734A (en) 1995-08-18 1997-05-06 University Technologies International, Inc. Filter for perfusion cultures of animal cells and the like
CA2422214A1 (en) 2000-10-02 2002-04-11 Novo Nordisk A/S Factor vii glycoforms
US7294484B2 (en) 2004-08-27 2007-11-13 Wyeth Research Ireland Limited Production of polypeptides
AU2006257073B2 (en) 2005-06-17 2011-08-04 Children's Medical Center Corporation ADAMTS13-comprising compositions having thrombolytic activity
DK2522717T3 (da) * 2006-01-04 2014-04-22 Baxter Int Oligopeptid-frie cellekulturmedier
PT2574677T (pt) * 2007-12-27 2017-10-19 Baxalta Inc Processos para cultura de células

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1596302A (zh) * 2001-11-28 2005-03-16 桑多斯有限公司 细胞培养方法

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ADAMTS13 gene defects in two brothers with constitutional thrombotic thrombocytopenic purpura and normalization of von Willebrand factor-cleaving protease activity by recombinant human ADAMTS13;ANTOINE G ETAL;<BRITISH JOURNAL OF HAEMATOLOGY>;20030301;第120卷(第5期);第821-824页 *
Continuous hybridoma suspension cultures with and without cell retention kinetics of growth, metabolism and product formation;ROBINSON D K ETAL;<JOURANL OF BIOTECHNOLOGY>;19920101;第22卷(第1-2期);第41-50页 *
Potential of Cell Retention Techniques;VOISARD D ETAL;<BIOTECHNOLOGY AND BIOENGINEERING>;20030630;第82卷(第7期);第751-765页 *

Also Published As

Publication number Publication date
EP3480292A1 (en) 2019-05-08
NZ597742A (en) 2014-02-28
EP2459697A1 (en) 2012-06-06
ES2705206T3 (es) 2019-03-22
EA201270213A1 (ru) 2012-06-29
SI2459697T1 (sl) 2019-03-29
CO6491119A2 (es) 2012-07-31
MX2012001274A (es) 2012-06-01
KR101752789B1 (ko) 2017-06-30
PT2459697T (pt) 2019-01-21
JP2013500710A (ja) 2013-01-10
US10745672B2 (en) 2020-08-18
BR112012002137A2 (pt) 2015-09-15
EP2459697B1 (en) 2018-10-17
AU2010277490A1 (en) 2012-02-09
KR20120038531A (ko) 2012-04-23
DK2459697T3 (en) 2019-01-28
WO2011012725A1 (en) 2011-02-03
CN102549142A (zh) 2012-07-04
CA2769354A1 (en) 2011-02-03
BR112012002137B8 (pt) 2020-05-12
EA022219B1 (ru) 2015-11-30
IN2012DN00899A (cg-RX-API-DMAC7.html) 2015-04-03
WO2011012725A8 (en) 2011-05-05
HRP20182165T1 (hr) 2019-03-08
MX353610B (es) 2018-01-18
TR201900213T4 (tr) 2019-02-21
US9650612B2 (en) 2017-05-16
BR112012002137B1 (pt) 2020-04-14
US10221400B2 (en) 2019-03-05
JP6177260B2 (ja) 2017-08-09
PL2459697T3 (pl) 2019-04-30
US20110086411A1 (en) 2011-04-14
AU2010277490B2 (en) 2014-08-28
US20180051261A1 (en) 2018-02-22
KR20170077286A (ko) 2017-07-05
US20140038264A1 (en) 2014-02-06
KR101885046B1 (ko) 2018-08-02
US8580554B2 (en) 2013-11-12
SG178176A1 (en) 2012-03-29
JP5808742B2 (ja) 2015-11-10
US20190153400A1 (en) 2019-05-23
JP2015062436A (ja) 2015-04-09

Similar Documents

Publication Publication Date Title
CN102549142B (zh) 在连续细胞培养中产生所关心多肽或病毒的方法
ES2375780T3 (es) Procedimiento de producción de un biopol�?mero (p.e. un polipéptido) en un proceso de fermentación continuo.
PT2634250T (pt) Processo melhorado para a cultura de células
CN104822821A (zh) 用于优化灌流细胞培养系统的方法和系统
AU2013203993B2 (en) Process for cell culturing by continuous perfusion and alternating tangential flow
Narumi et al. Recovery of human mesenchymal stem cells grown on novel microcarrier coated with thermoresponsive polymer
JP2008515412A (ja) ウイルス物質の製造方法
HK40008436A (en) Method of producing a polypeptide or virus of interest in a continuous cell culture
Mather Laboratory scaleup of cell cultures (0.5-50 liters)
HK1169439A (en) Method of producing a polypeptide or virus of interest in a continuous cell culture
HK1169439B (en) Method of producing a polypeptide or virus of interest in a continuous cell culture
CN102604884B (zh) 细胞的发酵培养方法
JPH05207874A (ja) 無血清培地
JPH05207875A (ja) 無血清培地
JP2011004754A (ja) 組換え安定細胞クローン、その産生およびその使用

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20160819

Address after: Aupu, Switzerland

Patentee after: Hundred deep limited liability company

Patentee after: Hundred deep company

Address before: Aupu, Switzerland

Patentee before: Bakst Helth Co., Ltd.

Patentee before: Baxter International Inc.

CP02 Change in the address of a patent holder

Address after: Zug City

Co-patentee after: Hundred deep company

Patentee after: Hundred deep limited liability company

Address before: Aupu, Switzerland

Co-patentee before: Hundred deep company

Patentee before: Hundred deep limited liability company

CP02 Change in the address of a patent holder
TR01 Transfer of patent right

Effective date of registration: 20210701

Address after: Osaka

Patentee after: TAKEDA PHARMACEUTICAL Co.,Ltd.

Address before: Zug City

Patentee before: BAXALTA GmbH

Patentee before: Baishen Co.

TR01 Transfer of patent right